TY - T1 - Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia SN - / UR - http://hdl.handle.net/10138/234503 T3 - A1 - European Soc Blood Marrow Transpla; HOVON-SAKK A2 - PB - Y1 - 2018 LA - eng AB - Background. Disease recurrence remains the major cause of death in adults with acute myeloid leukaemia (AML) treated using either intensive chemotherapy (IC) or allogenic stem cell transplantation (allo-SCT). Aims. The timely delivery of maintenance drug or cellular therapies represent emerging strategies with the potential to reduce relapse after both treatment modalities, but whilst the determinants of overall relapse risk have been extensively characterized the factors determining the timing ... VO - IS - SP - OP - KW - Acute myeloid leukaemia; stem cell transplantation; intensive chemotherapy; kinetics; maintenance therapy; STEM-CELL TRANSPLANTATION; 1ST COMPLETE REMISSION; MYELODYSPLASTIC SYNDROMES; EUROPEAN LEUKEMIANET; AZACITIDINE; TRIAL; AML; MAINTENANCE; OLDER; EBMT; 3122 Cancers; 3121 General medicine, internal medicine and other clinical medicine N1 - PP - ER -